Skip to main content
Caplight Logo









BioCorteX

BioCorteX

Private
LondonHealthcare & Life Scienceshttps://biocortex.com/

Last Round

Seed

Mar 28, 2023

Total Funding Raised

$5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

BioCorteX is a biotechnology company that operates a techbio platform to model the interactions between the microbiome, host, and treatments to de-risk the pharmaceutical pipeline.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

in-silico simulationdrug discoverymicrobiome modelingdigital twinprecision medicinetech-bioknowledge graphclinical trial designbiomarker discoverydrug-microbiome interactionAI drug discoverypredictive modelingpreclinical developmentdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioCorteX Comparables

Compare BioCorteX with similar companies based on industry and business-model similarity.

BioCorteX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Outpost Bio
84%
Pragma Bio
78%
QuantHealth
71%

BioCorteX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 28, 2023

Key People

Founding team and executive leadership

Nik Sharma

CEO Co-founder

Founding Team

BioCorteX Investors

Notable investors and investment history

BioCorteX investors
InvestorRounds
Hoxton VenturesSeed
Draper AssociatesSeed
Sofinnova PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 48% MoM.

  • Mar 28, 2023

    $5M round led by Hoxton Ventures and Sofinnova Partners.

BioCorteX Filings

Explore SEC and related filing metadata, where available.

BioCorteX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioCorteX's valuation, stock price, and market status.

Is BioCorteX a public or private company?

BioCorteX is a private company.

What is the current stock price of BioCorteX?

BioCorteX is a private company with no public stock price. No recent secondary market data is available.

How much is BioCorteX worth (valuation)?

Valuation information for BioCorteX is not publicly available.

Can I buy BioCorteX stock?

BioCorteX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioCorteX's last funding round?

BioCorteX's most recent funding round was Seed on March 27, 2023.

Who are the main investors in BioCorteX?

Key investors in BioCorteX include Hoxton Ventures, Sofinnova Partners.

Will BioCorteX IPO soon?

No public IPO plans have been announced for BioCorteX.

How can I track BioCorteX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioCorteX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2021
Last FundingMar 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?